The Global Hematology Analyzer Market is driven by growing geriatric population

Comments · 54 Views

Asia Pacific has displayed the fastest growth momentum in the Hematology Analyzer industry over the past few years due to improving healthcare infrastructure and expanding medical spending.

The Global Hematology Analyzer Market is estimated to be valued at US$ 4.94 Bn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Hematology Analyzer Market Trends are Boule Diagnostics AB, Bio-Rad Laboratories, Danaher Corporation, Sysmex, Horiba Medical, Nihon Kohden Corporation, Siemens AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Abbott, Drew Scientific, Diatron, EKF Diagnostics, F. Hoffmann-La Roche Ltd, Cormay Diagnostics, AGD Biomedicals, Pioneer Impex, BIOGENIX INC. PVT. LTD, and Drucker Diagnostics.

North America dominates the Hematology Analyzer market

North America has emerged as the largest market for hematology analyzers in terms of value. The region accounted for over 35% of the global market share in 2024 due to extensive healthcare spending and presence of major players. Several advanced medical facilities, large patient volumes, and growing demand for POC hematology devices are driving the North American market. Moreover, the rising prevalence of blood disorders like anemia, leukemia, and myeloma has prompted increased adoption of hematology testing in the region. The United States stands out as the single largest country market in North America.

Asia Pacific presents high-growth prospects

Asia Pacific has displayed the fastest growth momentum in the Hematology Analyzer industry over the past few years due to improving healthcare infrastructure and expanding medical spending. Factors such as the increasing awareness about blood-related conditions, growing geriatric population, favorable government policies, and developing distribution networks have supported the Asia Pacific market expansion. China and India have emerged as highly lucrative avenues due to their large population bases and rising access to diagnostics. Moreover, low manufacturing costs have attracted several multinational companies to set up production hubs in the region. Going forward, the Asia Pacific hematology analyzer market size is forecast to more than double by 2031.

Gets More Insights on: Hematology Analyzer Market

Comments